Merck KGaA executive board member to step down
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Merck KGaA said Walter Galinat is stepping down as executive board member on Sept. 30.
Galinat joined the German pharma major's executive board in 2016, and has been with Merck KGaA for 42 years. He is also stepping down as general partner at E. Merck KG.
